WHO ICTRP trial
Effect of efficacy and safety study of remimazolam tosilate in bronchoscopy: a…
ChiCTR2000035214 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000035214 |
|---|---|
| Public title | Effect of efficacy and safety study of remimazolam tosilate in bronchoscopy: a randomized controlled trial. |
| Scientific title | Effect of efficacy and safety study of remimazolam tosilate in bronchoscopy: a randomized controlled trial. |
| Primary sponsor | The First Affiliated Hospital of Guangxi Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Anesthetic |
| Interventions | trial group:Remimazolam;control group:Propofol |
| Registration date | Aug 4, 2020 |
| Target size | trial group:40;control group:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: